Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation

Bone Marrow Transplantation

Volumn 49, Issue 10, 2014, Pages 1310-1316

  Tavadze, M ^a   Rybicki, L ^a   Mossad, S ^a   Avery, R ^b   Yurch, M ^c   Pohlman, B ^c   Duong, H ^c   Dean, R ^c   Hill, B ^c   Andresen, S ^c   Hanna, R ^a   Majhail, N ^c   Copelan, E ^d   Bolwell, B ^c   Kalaycio, M ^c   Sobecks, R ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Division of Infectious Diseases   (United States)

^c TAUSSIG CANCER INSTITUTE   (United States)

^d LEVINE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; COHORT ANALYSIS; COMORBIDITY; DISEASE ASSOCIATION; DONOR; ENTEROCOCCAL INFECTION; FEMALE; HEMATOLOGIC DISEASE; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME; UMBILICAL CORD BLOOD DONOR; UNRELATED DONORS; VANCOMYCIN RESISTANT ENTEROCOCCUS BACTEREMIA; ADOLESCENT; ADVERSE EFFECTS; BACTEREMIA; ENTEROCOCCUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; MIDDLE AGED; SURVIVAL; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BACTEREMIA; ENTEROCOCCUS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; YOUNG ADULT;

EID: 84926409063     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2014.150     Document Type: Article

References (33)

1. DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 2005; 41: 327-333.
2. Olivier CN, Blake RK, Steed LL, Salgado CD. Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE. Infect Control Hosp Epidemiol 2008; 29: 404-409.
3. Kuehnert MJ, Jernigan JA, Pullen AL, Rimland D, Jarvis WR. Association between mucositis severity and vancomycin-resistant enterococcal bloodstream infection in hospitalized cancer patients. Infect Control Hosp Epidemiol 1999; 20: 660-663.
4. Bhavnani SM, Drake JA, Forrest A, Deinhart JA, Jones RN, Biedenbach DJ et al. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia. Diagn Microbiol Infect Dis 2000; 36: 145-158.
5. Ghanem G, Hachem R, Jiang Y, Chemaly RF, Raad I. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients. Infect Control Hospital Epidemiol 2007; 28: 1054-1059.
6. Serody J. Bacterial sepsis and GI tract GVHD: more commensal than you think. Blood 2012; 120: 6-7.
7. Eriguchi Y, Takashima S, Oka H, Shimoji S, Nakamura K, Uryu H et al. Graft-versushost disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of alpha-defensins. Blood 2012; 120: 223-231.
8. Lukenbill J, Rybicki L, Sekeres MA, Zaman MO, Copelan A, Haddad H et al. Defining incidence, risk factors, and impact on survival of central line-associated blood stream infections following hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome. Biol Blood Marrow Transplant 2013; 19: 720-724.
9. Kelly M, Conway M, Wirth K, Potter-Bynoe G, Billett AL, Sandora TJ. Moving CLABSI prevention beyond the intensive care unit: risk factors in pediatric oncology patients. Infect Control Hosp Epidemiol 2011; 32: 1079-1085.
10. Avery R, Kalaycio M, Pohlman B, Sobecks R, Kuczkowski E, Andresen S et al. Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course. Bone Marrow Transplant 2005; 35: 497-499.
11. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825-828.
12. Vogelsang GB. How I treat chronic graft-versus-host disease. Blood 2001; 97: 1196-1201.
13. Sobecks RM, Ball EJ, Askar M, Theil KS, Rybicki LA, Thomas D et al. Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2008; 41: 709-714.
14. Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005; 106: 2912-2919.
15. Zhang H BS. Recursive Partitioning in the Health Sciences. Springer-Verlag: New York, 1999.
16. Fine JP GR. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94: 496-509.
17. Vergis EN, Hayden MK, Chow JW, Snydman DR, Zervos MJ, Linden PK et al. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study. Ann Intern Med 2001; 135: 484-492.
18. Morris Jr JG, Shay DK, Hebden JN, McCarter Jr RJ, Perdue BE, Jarvis W et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann Intern Medicine 1995; 123: 250-259.
19. Vydra J, Shanley RM, George I, Ustun C, Smith AR, Weisdorf DJ et al. Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2012; 55: 764-770.
20. Kamboj M, Chung D, Seo SK, Pamer EG, Sepkowitz KA, Jakubowski AA et al. The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Biol Blood Marrow Transplant 2010; 16: 1576-1581.
21. McKinnell JA, Patel M, Shirley RM, Kunz DF, Moser SA, Baddley JW. Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents. Epidemiol Infect 2011; 139: 1342-1350.
22. Cumpston A, Craig M, Hamadani M, Abraham J, Hobbs GR, Sarwari AR. Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit. Transplant Infect Dis 2013; 15: 142-149.
23. Poutsiaka DD, Skiffington S, Miller KB, Hadley S, Snydman DR. Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients. J Infect 2007; 54: 567-571.
24. DiazGranados CA, Jernigan JA. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection. J Infectious Dis 2005; 191 : 588-595.
25. Ornstein M MS, Keng MK, Elson P, Tiu RV, Saunthararajah Y, Farhat L et al.. Vancomycin-Resistant Enterococcus (VRE) Bacteremia During Acute Myeloid Leukemia (AML) Induction Therapy Is an Independent Predictor of Poor Outcome. Blood 2012; 120: abstr# 1487.
26. Yoo JH, Lee DG, Choi SM, Choi JH, Shin WS, Kim M et al. Vancomycin-resistant enterococcal bacteremia in a hematology unit: molecular epidemiology and analysis of clinical course. J Korean Med Sci 2005; 20: 169-176.
27. Weinstock DM, Conlon M, Iovino C, Aubrey T, Gudiol C, Riedel E et al. Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant 2007; 13: 615-621.
28. Johnston PB EM, Ansell SM, Dispenzieri A, Gastineau DA, Gertz MA et al. Colonization with vancomycin resistant enterococcus correlates with poor outcome in patients undergoing allogeneic blood and marrow transplants. Blood 2000; 96: 786a.
29. Zirakzadeh A, Gastineau DA, Mandrekar JN, Burke JP, Johnston PB, Patel R. Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2008; 41 : 385-392.
30. Kang Y, Vicente M, Parsad S, Brielmeier B, Pisano J, Landon E et al. Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients. Transplant Infect Dis 2013; 15: 466-473.
31. Kraft S, Mackler E, Schlickman P, Welch K, DePestel DD. Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients. Support Care Cancer 2011; 19: 1969-1974.
32. Hicheri Y, Einsele H, Martino R, Cesaro S, Ljungman P, Cordonnier C. Environmental prevention of infection in stem cell transplant recipients: a survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Transplant Infect Dis 2013; 15: 251-258.
33. Centers for Disease C, Prevention. Vital signs: central line-associated blood stream infections - United States, 2001, 2008, and 2009. Morbid Mortality Wkly Rep 2011; 60: 243-248.